NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nath Bio-Genes has submitted its Annual Secretarial Compliance Report for the financial year ended 31st March 2025 to BSE and NSE. The report was prepared by M/s Neha P Agrawal, a Practicing Company Secretary, as required under Regulation 24A of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. This is a yearly mandatory filing that confirms whether the company has complied with applicable SEBI regulations, listing rules, and corporate governance norms during the financial year. The submission was signed by Amol Gupta, Chief Financial Officer, on 30th May 2025.
This is a routine regulatory compliance submission with no direct impact on business or stock price. Investors can review the attached report to check for any deviations or non-compliance issues flagged by the secretarial auditor.